Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Plos One|August 4, 2017
Acute and chronic effects of exercise on mRNA expression in the skeletal muscle of two mouse models of peripheral artery diseaseHiroki Nagase, Shuhei Yao, Shota IkedaInternal Medicine (Tokyo, Japan)|December 7, 2020
Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing PolychondritisYusuke Hanioka, Katsushu Shimizu, Keiko Yamagami, et al.Modern Rheumatology Case Reports|February 8, 2022
A case of TAFRO syndrome maintained in remission for 5 years after discontinuation of tocilizumabKeiko Yamagami, Yusuke Hanioka, Shuhei Yao, et al.International Journal of General Medicine|November 10, 2021
Recent Outpatient Services in General Internal Medicine: 6.4% of Symptomatic Patients Were Post-Acute COVID-19Yusuke Hanioka, Ryo Morita, Keiko Yamagami, et al.Scientific Reports|February 6, 2020
Nucleus accumbens pathways control cell-specific gene expression in the medial prefrontal cortexTakatoshi Hikida, Shuhei Yao, Tom Macpherson, et al.Bioorganic & Medicinal Chemistry Letters|November 14, 2012
Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitorsYoshito Terao, Hideo Suzuki, Masato Yoshikawa, et al.Journal of Medicinal Chemistry|March 2, 2012
Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffoldsMasanori Okaniwa, Masaaki Hirose, Takashi Imada, et al.Annals of the Rheumatic Diseases|April 2, 2026
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective studyYohei Kirino, Ayaka Maeda, Kana Higashitani, et al.Pageof 1